Michael Dybbs Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael Dybbs.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Dybbs. Michael Dybbs is a Director in SUTRO BIOPHARMA INC ($STRO) and a Director in Versartis, Inc. ($VSAR) and a Director in Dimension Therapeutics, Inc. ($DMTX) and a Director in Nkarta, Inc. ($NKTX).
Address: C/O NEW LEAF VENTURES TIMES SQ. TOWER, 7 TIMES SQ., STE. 3502 NEW YORK 10036 NY
Companies in which Michael Dybbs is an Insider
Aravive, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Dybbs: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 24 2014
$ARAV Market Capitalization: $474.95M
$ARAV Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Dimension Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Michael Dybbs: Director
Holdings: 2,059,283 shares
Current Value: $3,397,817
Latest Transaction: Nov 07 2017
$DMTX Market Capitalization: $41.32M
$DMTX Previous Close: $1.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Nkarta, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Dybbs: Director
Holdings: 0 shares
Latest Transaction: Jun 15 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SUTRO BIOPHARMA, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Michael Dybbs: Director
Holdings: 0 shares
Latest Transaction: Jun 08 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Michael Dybbs
Sentiment: All, ARAV, DMTX, NKTX, STRO
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2021 | NKTX | Nkarta, Inc. | Dybbs Michael | Director | Option Exercise | A | 25.03 | 16,511 | 413,270 | 16,511 | |
| Jul 13 2020 | NKTX | Nkarta, Inc. | Dybbs Michael | Director | Option Exercise | A | 18.00 | 10,700 | 192,600 | 10,700 | |
| Jul 13 2020 | NKTX | Nkarta, Inc. | Dybbs Michael | Director | Option Exercise | A | 18.00 | 10,700 | 192,600 | 10,700 | |
| Jun 08 2020 | STRO | SUTRO BIOPHARMA, I ... | Dybbs Michael | Director | Option Exercise | A | 9.83 | 12,000 | 117,960 | 12,000 | |
| Jun 19 2019 | STRO | SUTRO BIOPHARMA, I ... | Dybbs Michael | Director | Option Exercise | A | 11.12 | 11,610 | 129,103 | 11,610 | |
| Sep 27 2018 | STRO | SUTRO BIOPHARMA IN ... | Dybbs Michael | Director | Option Exercise | A | 15.00 | 26,033 | 390,495 | 26,033 | |
| Nov 07 2017 | DMTX | Dimension Therapeu ... | Dybbs Michael | Director | Option Exercise | D | 1.15 | 17,000 | 19,550 | 0 |